AHFS Drug Information® 2024

With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.

Updates in this edition include*:

• Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
• Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
• Contemporary topics such as changes in mifepristone REMS requirements, off-label use of misoprostol, and ongoing alterations to use of the COVID-19 vaccines 
• Expanded firstRelease documents for gene therapies 
• Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccines
• Expanded content on off-label uses and long-term clinical data
• MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications
• New content on over 100 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 150 medications

For bulk or institutional purchases, contact ASHP Sales and Business Development here.

*both print and electronic versions

Published under the Editorial Authority of ASHP^®
American Society of Health-System Pharmacists^®

EDITORIAL STAFF
Senior Vice President, Office of Professional Development and Publishing: Daniel J. Cobaugh, PharmD, DABAT, FAACT
AHFS Editor-in-Chief and Senior Editorial Director: Michael Gabay, PharmD, JD, BCPS, FCCP
Deputy Editor-in-Chief: Shingyee Cindy Huang, PharmD 
Principal Editorial Contributors: The University of Illinois at Chicago Drug Information Group
Editorial Contributors: Nicole Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP; Linda Bedford Arcuri, PharmD; Natalie A. Mendham, PharmD; Cambrey Bao-Phuong Nguyen, PharmD; Heather Draper, PharmD, BCPS, BCEMP; Elaine K. Snow, BS Pharm; Karen M. Whalen, BS Pharm, BCPS, FASHP; and Barbara F. Young, PharmD, MHA
Contributors: Auburn University Drug Information Service; Belmont University Drug Information Service; Creighton University Drug Information Service; Medical University of South Carolina Drug Information Service; the University of Arizona Drug Information Service; the University of Missouri, Kansas City Drug Information Service; and the University of Rhode Island Drug Information Service
Assistant Editor for Injectable Drug Information: Natalie C. Rosanelli, PharmD 
Clinical Informatics Analyst: Kevin Son, PharmD, MHI 
Project Manager: Elizabeth P. Shannon, BS
Director of Production and Platform Services: Johnna Hershey, BA
Editorial Coordinator: Alexandra Rallo, BA

FORMER EDITORS
Charles B. Cleveland
Donald E. Francke
William M. Heller
Judith A. Kepler
George P. Provost
Mary Jo Reilly
Gerald K. McEvoy
Elaine K. Snow

AHFS ONCOLOGY EXPERT COMMITTEE
Chase Ayres, PharmD, BCOP
Jason Bergsbaken, PharmD, MBS, BCOP
Rachel Bubik, PharmD, BCOP, BCPS
Caroline Clark, MSN, APRN, OCN, AG-CNS
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
Christine Gegeckas, RPh, BCOP
Chelsea Gustafson*, PharmD, BCOP
Kirollos Hanna, PharmD, BCPS, BCOP
Tara Higgins*, PharmD, BCPS, LECOM
Isabel Houlzet*, PharmD, BCPS, BCOP
Andrew (Weiyi) Li, PharmD
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP
Eve Segal, PharmD, BCOP
Kate Taucher, PharmD, MHS, BCOP, FASHP, FAPO
John Villano, MD, PhD
Kathleen Wiley, MSN, RN, AOCNS

* Appointed in cooperation with the Hematology/Oncology Pharmacy Association (HOPA)

"AHFS DI has maintained itself as a premier, evidence-based drug compendium. Even in the era of digital, online use, AHFS DI has evolved...and offers its information both in print and online.

What sets AHFS DI apart from the [other drug information books available] is its comparative, unbiased, evaluative drug information and its continually maintained relevance. It has been vetted through multiple channels of review and has consistently been recognized as the gold standard of where to obtain drug information."

Patrick J. Scoble, PharmD, Doodys Review Service

"This book succeeds in offering an updated drug compendium of evidence-based drug monographs, meeting the needs of today's healthcare professionals. The reference continues to be trustworthy, relying on the most prestigious and knowledgeable drug experts in the medical field.

This reference can be used by any healthcare professional utilizing or prescribing medications in their practice, including physicians, pharmacists, physician assistants, and nurse practitioners. The book is so nicely organized and easily referenced that it can also be used by students in the medical, pharmacy, and nursing fields as well."

Melissa M. Potts, BS, PharmD, Doodys Review Service